Physician profile
Tianyi Tim Wang
NPI 1639469349
$141,383.52
in general payments reported to CMS, 2019-2025
20 companies · $98K in 2025
The $98K reported for 2025 was more than what 97% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,440 · 2020: $4,257 · 2021: $5,144 · 2022: $2,271 · 2023: $15K · 2024: $14K · 2025: $98K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $68K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Travel and Lodging: $8,829 · Food and Beverage: $6,775 · Entertainment: $18.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $67,525.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44,125.00 |
| Travel and Lodging | $8,828.50 |
| Food and Beverage | $6,774.85 |
| Entertainment | $18.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $56,556.64 | 2021-2025 | Arthrex |
| Joint Restoration Foundation, INC. | $29,003.60 | 2022-2025 | |
| Moximed, INC | $23,232.91 | 2025 | Misha Knee System, Small, Left |
| Miach Orthopaedics, INC. | $13,558.60 | 2023-2024 | |
| Evolution Surgical, INC | $10,338.09 | 2019-2021 | |
| Linvatec Corporation | $2,873.92 | 2022-2025 | Biobrace 23mm |
| Elevate Surgical Co | $1,459.85 | 2023-2025 | |
| Bioventus LLC | $1,118.41 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $631.93 | 2022-2025 | Bone Anchors With Arthroscopic Delivery System, Novostitch, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Depuy Synthes Sales INC. | $623.92 | 2022-2025 | Healix Knotless Peek, Truespan Orthocord, Milagro |
| Impactortho, INC. | $532.13 | 2021-2022 | |
| Stryker Corporation | $499.25 | 2022-2025 | Inspace, Blueprint Patient Specific Instrumentation, Variax |
| Overture Orthopaedics | $186.65 | 2025 | Overtureti |
| Vericel Corporation | $159.22 | 2022-2023 | Maci |
| Cartiheal (2009) Ltd. | $146.15 | 2023 | Agili-C |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Breg, INC | $122.72 | 2022 | |
| Bodycad USA Corp | $112.29 | 2024 | Fine Osteotomy |
| Zimmer Biomet Holdings, INC. | $87.99 | 2021-2024 | Comprehensive, Avenir |
| Newclip USA LLC | $70.43 | 2025 | |
| Suvon Surgical LLC | $68.82 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$26,869.44 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tianyi Tim Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.